ãæ¸è©ãããªããã·ã¹ãã éçºã¯å¿ ãã¢ã¡ãã®ãï¼ 49ã®ãã©ãã«ããå¦ã¶ããã¸ã§ã¯ã管çè¡ãï¼ç´°å·ç¾©æ´ã»èï¼ èªãã§ãã¦ãå®ç¨æ¸ãªã®ã«æ¶ãæ¢ã¾ããªãæ¬ã«å·¡ãä¼ããã®ã§è¬¹ãã§ã奨ãããã¦ããã ãã¾ãã ãã®åããããªããã·ã¹ãã éçºã¯å¿ ãã¢ã¡ãã®ã? 49ã®ãã©ãã«ããå¦ã¶ããã¸ã§ã¯ã管çè¡ããä½ãã¤ãã¤ã£ã¦ããã¡ãã¡æ²è¼ããã¦ããé ç®ãã¤ãã¤ããããªããä½åº¦ãè¦ä»¶ã追å ãã¦ããã¦ã¼ã¶ãã§ãããã¾ãã§å¼ç¤¾ã®æ顧客ã§ã¯ãªãã§ããã 大é ç®ãããã¦ãè¨è¨ããããããã°ã©ãã³ã°ããããã¹ããã¨ãé²ãå ã ã«ã³ã£ããã¨å°é·ãæ·ãè©°ãããã¦ãããã ãããªãã¨æªãæ±ããããã«ã¯ããããªãä¸çãåºãããæå¾ã«ã¯ã決ã¾ãã®ãå¥ç´ããããã¼ãèªãã§ãã¦ãããããã¾ãããç¹ã«ãä»®çºæ³¨æ¸ã ãã§ä½æ¥ã«çæãã¦ãã¾ã£ããï¼ãã¨ãããªããè¦éãããã¦ããããã§ãããã¾ããæ¥ççã«ã¯å¾ã ã«ãã¦èµ·ããã¡ãªãã¨ãä¸è¬è«ã¨ãã¦æ¸ã
â¾à ç¶â¾à¢ èªå¦çà¾åéã«ããã ãã£ã¼ãã©ã¼ãã³ã°ã®ç¾ç¶ 渡éâÌé½å¤ªéྠæ±åà¾â¼¤Öå¦â¼¤Öå¦é¢æ å ±ç§å¦ç ç©¶ç§ IBIS2013 ä¼ç»ã»ãã·ã§ã³2ï¼ãã£ã¼ãã©ã¼ãã³ã° 2013/11/12 NLPã«ããããã£ã¼ãã©ã¼ãã³ã° 2 â¾à¢ èªã¢ãã« ã®æ§ç¯ â¾à¢ èªã®æ§ææ§ ã®ã¢ãã«å æ§æçæå³è«à¾ â¾à¢ èªè§£æ ï¼æ§é äºæ¸¬ï¼ Recursive Neural Networks Autoencoders (Socher et al., 2011, 2012, 2013) RBM (Minh and Hinton 2007) Feed-forward Deep NN (Bengio et al., 2003, Arisoy et al., 2012) Recurrent NN (Mikolov et al., 2010) (Wang and Manning 2013) (Mansur et al.,
PostgreSQLã¯ãã¯ããã ã®ãã¼ã¿ãã¼ã¹ã«ããã âPostgreSQLã«ã³ãã¡ã¬ã³ã¹2013 åºèª¿è¬æ¼ã¬ãã¼ã Not so much as a database as a data Platformï¼åãªããã¼ã¿ãã¼ã¹ãè¶ ãããã¼ã¿ãã©ãããã©ã¼ã ã¨ãã¦ã®åå¨â ï¼â â11æ8æ¥ãé½å ã§éå¬ããããPostgreSQLã«ã³ãã¡ã¬ã³ã¹2013ãï¼â 主å¬: æ¥æ¬PostgreSQLã¦ã¼ã¶ä¼ï¼ã®åºèª¿è¬æ¼ã«ç»å£ããHerokuéçºè ã®ãã¼ã¿ã¼ã»ã²ã¼ã¬ã³ï¼Peter Geogheganï¼æ°ã¯PostgreSQLããã表ç¾ãã¾ããã æ¥å¹´ã«ã¯æ¬¡ãã¼ã¸ã§ã³ã®PostgreSQL 9.4ã®ãªãªã¼ã¹ãæå¾ ããã¦ãã¾ãããã²ã¼ã¬ã³æ°ã®è¨ã"ãã¼ã¿ãã©ãããã©ã¼ã "ã¨ãã¦PostgreSQLã¯ã©ã®ãããªé²åãéãããã¨ãã¦ããã®ã§ãããããæ¬ç¨¿ã§ã¯ã®åºèª¿è¬æ¼ã®å 容ããã¨ã«ãPostgreSQLã®æ¬¡ãªã
ãã©ãã¿ãªã¦ã ã¯ãªã¨ã¤ã¿ã¼ã§ãã大平貴ä¹ããããã¨ã¤ããæãç«ã£ã¦å®æ½ãããå¤æ©ä¸éµããã¬ã¼ã¶ã¼å ãçºå°ãã¦20ããé¢ããå æ¬æ¨ãã«ãºã§è¦³æ¸¬ããã¨ããå®é¨ããã¦ããã®èå°è£ãããã«ã â»è¿½è£ç·¨ãã覧ä¸ããããhttp://togetter.com/li/589923
ã³ã¼ãã¼ãä¸çªå¹ãã®ã£ã¦æ¬å½ã¯ä½æãªãã ãããªâ¦ã£ã¦èãããã¨ãªãã§ããï¼ åå¾ã¯å¥½ã¾ãããªããç¹ã«å¯ä»ããæªã人ã¯ãã£ã¦è¨ããã¾ããã©ãã§ãããã§ããªãããããªãããªã¼ã£ã¦ãã èªåã¯æã ããã¾ããããªããï¼ ããããã¡ãã¨ç解ããã«ã¯ãï½¢æéè¬çå¦ï¼chronopharmacologyï¼ï½£ã¨ããã誰ãããã¾ã話é¡ã«ã®ã¼ãããã¨ããªãã®ã ãã©é常ã«é¢ç½ãã³ã³ã»ãããã¾ãç解ããªããã°ãªãã¾ããã ï½¢æéè¬çå¦ï¼chronopharmacologyï¼ï½£ã¨ã¯ãçä½ãªãºã ã¨è¬å¹ã®ç¸é¢é¢ä¿ã®å¦åã®ãã¨ãçä½ãªãºã ã®ä¸ã§ãä¸çªéè¦ãªãã®ã®ã²ã¨ã¤ããä½å æè¨ã§ããå çã®24æéå¨æã®æè¨ã«å¿ãã¦ãåãã®ççæ©è½ãè¡åãæ§ã ã«å¤ããããè¬ã®ç¹æ§ââä¾ãã°è¬ã®å®å ¨æ§ï¼å»è¬åå®å ¨ç£è¦ä½å¶[pharmacovigilance]ï¼ãè¬ç©åæ ï¼pharmacokineticsï¼ãè¬ã®æå¹æ§ï¼drug effic
ããã³ãå å·¥ããéã«å»æ£å¦åãã¦ããç ®æ±ã¨å èããæ©è½æ§æåãæ½åºãã¦ãæ°´è«èãæãããããã³é´ä¸ãããããããä¿æ¹¿ä½ç¨ããããã£ãããå粧水ãªã©ã®æ°ååãä½ãåããé森å¸ã§å½¢ã«ãªãã¤ã¤ããã å®ä¾¡ã§çç£ã§ãã¦éè¦ãè¦è¾¼ã¾ããããã³å å·¥æã®ãã¿å¦çã³ã¹ããåæ¸ã§ããã¨ãã£ã¦ãé¢ä¿è ã®æ³¨ç®ãéã¾ãã äºæ¥ã«åãçµãã®ã¯åå¸å¸çºã®æ°´ç£å å·¥æ¥ã大è±ãï¼å¹³æ²¢å¤§è¼ç¤¾é·ï¼ãå¼å大ã®ç 究ã§ããã³æåã®å¹æãè£ä»ããé森éè¡ã®èè³2500ä¸åã¨ãå°å ´ç£æ¥ãè²æããç·åçã®è£å©é5000ä¸åãåãããç£å¦éå®ãã®é£æºäºæ¥ã¨ãªããå¸ãã³ã¼ãã£ãã¼ãå½¹ãåãã11æ¥ã«ã¯4è ã®æè¦äº¤æä¼ãå¸å ã§éãããã é森çã®ããã³æ¼ç²éã¯åæµ·éã«æ¬¡ãã§å ¨å½2ä½ãå¼å大ã®æ¸è°·é·çã»ããã³ç 究ã»ã³ã¿ã¼é·ã«ããã¨ãããã³ã®ç ®æ±ããæ½åºããããµããã³ã¯æèãæããä½ç¨ããããæ°´è«èãæããå¹æãªã©ãããã¨ãããå èã«å«ã¾ãã
ãã¯ã«ã¼ãã³ã®ãã¨ã¯ããããã©ããã§ãä½ããã®å½¢ã§å¦ã°ãªããã°ãããªãã¨ãã£ã¨æã£ã¦ãã¾ããã ãã¼ã·ã£ã«ã»ãã¯ã«ã¼ãã³ãã«ããåºèº«ã®è±æå¦è ã§ææ³å®¶ãã³ãã¥ãã±ã¼ã·ã§ã³çè«ãã¡ãã£ã¢è«ã®å¤§å®¶ã¨ãã¦1960年代ã«æ´»èºãããã¡ãã£ã¢ã¯ã¡ãã»ã¼ã¸ã§ããããå°çæããªã©ã¨ãã£ãè¨èãæ¦å¿µãçã¿åºãã人ç©ã¨ãã¦èåã§ãããã®ã®ãå®éã®ã¨ããä¸è¬ã®èªè ãä½ã®ç¨æããªãã«åå ¸ã«ãããã®ã¯ãªããªãé£ããæ¸ãæããããã¾ããã ããããã®ã¯ãããã¯ã«ã¼ãã³ã¯ä½ç³»çã§ããããããå®è¨¼çãªçè«ã¨ãã¦èªèº«ã®ææ³ãæ示ãã¦ã¯ããããçãè¦å¥ã®ãããªè¨èããæ¦å¿µãå®é¨çã«æ示ãããã¨ã§èªèº«ã®èãã表æããããããªãã°åã»å®è¨¼çãªææ³ãç¨ãããã¨ãå¤ãã£ãããã§ãã ããã¯ãã¯ã«ã¼ãã³èªèº«ã®é åã§ããããå½¼ã®ææ³ããã¾ãªãæ´»åãå¾ã¦ããåã®æºæ³ã§ãããã®ã§ãããããããå¦ã¼ãã¨ãã¦ããæéã®ãªã人ã«ã¯å°ã£ã話ã§ãã
大éã§ããå¯ããªãã¾ãããã ç¾å¨ãã¤ãªããã¸ã§ã¯ãã®ãªã¼ãã¼ãåãã¦ãã¾ããæè¿å¤é¨ã®ã©ã¤ããµã¤ã¨ã³ã¹æ©é¢ã¨åæ¥ã«é¢ãããã¬ã¹ãªãªã¼ã¹ãããã¤ããããåé¿ãå¤ãé ãã¾ãããæè§ã®æ©ä¼ã§ãã®ã§PFIã§ã®ãã¤ãªã»ãã«ã¹ã±ã¢ã»å»çåéã§ã®ããã¾ã§ã®åãçµã¿ãä»å¾ã®æ¹åæ§ã«ã¤ãã¦ç´¹ä»ãããã¦ããã ãããã¨æãã¾ãã 次ä¸ä»£ã·ã¼ã±ã³ãµã¼ãªã©ãå§ãã¨ãã¦ããã¤ãªã»å»çã»ãã«ã¹ã±ã¢åéã§ã¯èç©ããããã¼ã¿éã¯ççºçã«å¢å ãã¦ãã¾ãããããããããã®è§£ææè¡ã¯ç 究ã¬ãã«ã§ã¯æ°å¤ãåå¨ãããã®ã®ããããã³ã°ããã¾ãããããå®éã®ç¾å ´ã§æ´»ããã¦ããªãã±ã¼ã¹ãå°ãªããªãããã§ãããã¤ãªããã¸ã§ã¯ãã§ã¯ãããã®åéã§ç¾ãããã¼ã¿ã«å¯¾ãã¦æ å ±æ¤ç´¢æè¡ãæ©æ¢°å¦ç¿æè¡ãæ´»ç¨ããäºãç®æ¨ã¨ãã¦åãçµãã§ãã¾ãã ããã¯PFIãéçºã«æºãã£ã¦ããæ©æ¢°å¦ç¿åºç¤Jubatusã®å°æ¥ã®å¿ç¨å ã説æããå³ã§ããä»å¾ã®é©ç¨é åã¨ã
å é±æ«ã«ï¼ãå°å ´ã§ãµã¤ã¨ã³ã¹ã¢ã´ã©ã¨ããç§å¦ã³ãã¥ãã±ã¼ã·ã§ã³ã®ç¥å ¸ã«ãã¹ã±ãããåºå±ãã¦ãã¾ããï¼ ããã¹ã±ããã«ããããã°ã©ãã³ã°å ¥éã ãµã¤ã¨ã³ã¹ã¢ã´ã©ã¯6å¹´ç®ã ããã§ï¼ãã¹ã±ããã¯ååºå±ã§ãï¼ ãã£ã¦ã¿ãææ³ã¨ãã¦ã¯ï¼åä¾ãã¡ã«å¤§äººæ°ï¼å¹¼ç¨åå ã§ã楽ããã§ã§ããã®ã§ï¼äºæ¥éã§ä½åº¦ã足ãéãã§ããã人ããã¦ï¼åãã®ãã¼ã¹ã ãã¡ãã£ã¨éãé°å²æ°ã§ããï¼ãé£ã®é»ã©ãææãä»æã¨ã¯éãé°å²æ°ã§ãããï¼ï¼åãã¡ã¯ï¼ãã£ã¨ããããªå®¢å±¤ãç¸æã«ãã¹ã±ããã®ã¤ãã³ãããã£ã¦ãã¾ãããï¼ãããªç§å¦æè²ã«ç解ã®ããã家åºã®ãåãããã¡ã«ã¯ï¼ãã®ãããããæãã£ãã§ãï¼ã¿ããªé ãè¯ããï¼ç´ ç´ã ãï¼ããã¨åã¯ï¼è²ã ãªç§å¦é¤¨ã®æ¹éã¨ãã話ã§ãããï¼ç±å¿ãªè¦ªå¾¡ããã¨ãã話ã§ãããï¼åºå±ãã¦ããã£ãã§ãï¼ ãµã¤ã¨ã³ã¹ã¢ã´ã©ã¯åããç¥ã£ã¦ã¾ãããï¼ããã¾ã§åºå±ããã®ã«å°ãæµæãããã¾ããï¼ãã®çç±ã¯ãããã°ã©ãã³
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}